Tudor Investment Corp’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,088
| Closed | -$247K | – | 2145 |
|
|
2021
Q1 | $247K | Sell |
3,088
-8,466
| -73% | -$661K | 0.01% | 1368 |
|
|
2020
Q4 | $911K | Sell |
11,554
-23,649
| -67% | -$1.39M | 0.03% | 724 |
|
|
2020
Q3 | $1.55M | Sell |
35,203
-3,744
| -10% | -$184K | 0.07% | 396 |
|
|
2020
Q2 | $1.72M | Buy |
38,947
+29,278
| +303% | +$1.09M | 0.09% | 297 |
|
|
2020
Q1 | $347K | Buy |
+9,669
| New | +$550K | 0.03% | 634 |
|
|
2019
Q1 | – | Sell |
-17,348
| Closed | -$1.29M | – | 1330 |
|
|
2018
Q4 | $1.29M | Sell |
17,348
-17,587
| -50% | -$1.45M | 0.03% | 310 |
|
|
2018
Q3 | $3.22M | Buy |
34,935
+25,960
| +289% | +$2.47M | 0.08% | 166 |
|
|
2018
Q2 | $883K | Buy |
+8,975
| New | +$1M | 0.03% | 479 |
|
|
2017
Q4 | – | Sell |
-5,365
| Closed | -$505K | – | 1361 |
|
|
2017
Q3 | $505K | Buy |
5,365
+1,687
| +46% | +$133K | 0.01% | 633 |
|
|
2017
Q2 | $287K | Buy |
+3,678
| New | +$276K | 0.01% | 773 |
|
|
2016
Q4 | – | Sell |
-3,000
| Closed | -$234K | – | 1692 |
|
|
2016
Q3 | $234K | Sell |
3,000
-3,400
| -53% | -$247K | 0.01% | 1172 |
|
|
2016
Q2 | $440K | Buy |
6,400
+700
| +12% | +$48.3K | 0.01% | 926 |
|
|
2016
Q1 | $407K | Sell |
5,700
-2,200
| -28% | -$138K | 0.01% | 1102 |
|
|
2015
Q4 | $491K | Buy |
+7,900
| New | +$482K | 0.01% | 894 |
|
|
2014
Q1 | – | Sell |
-10,600
| Closed | -$359K | – | 1468 |
|
|
2013
Q4 | $359K | Buy |
+10,600
| New | +$367K | 0.02% | 780 |
|
Tudor Investment Corp's CMD Position: Q2 2021 in Review
Tudor Investment Corp sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3,088 shares — an estimated $247K sold.
Tudor Investment Corp first reported a position in CMD in Q4 2013 and held it in 15 quarters. The position peaked at $3.22M in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Tudor Investment Corp reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Tudor Investment Corp sold 3,088 Cantel Medical Corporation shares in Q2 2021, an estimated $247K.
- Tudor Investment Corp first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 15 quarters.
- Tudor Investment Corp's Cantel Medical Corporation position peaked at $3.22M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.